Oral sustained release formulation of tedisamil with gastric retention properties

Details for Australian Patent Application No. 2005256653 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors De Winter, Marius L.; Bakker, Johan A.; Fabiano, Santa

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005256653

PCT Pub. Number WO2006/000583

Priority 04102987.7 28.06.04 EP; 60/582,798 28.06.04 US

Filing date 27 June 2005

Wipo publication date 5 January 2006

Acceptance publication date 14 October 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

15 February 2007 PCT application entered the National Phase

  PCT publication WO2006/000583 Priority application(s): WO2006/000583

14 October 2010 Application Accepted

  Published as AU-B-2005256653

10 February 2011 Standard Patent Sealed

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005256659-4,6-disubstituted pyrimidines and their use as protein kinase inhibitors

2005256643-Improvements relating to optical brightening agents